ConductScience.org, home

Paper7205804

The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives.

Ramcharan S and 3 others. J Reprod Med, 1980. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives. Papers, record 7205804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7205804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives.
PubMed
Journal
J Reprod Med
PubMed
Year
1980
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.94
iCite
Revised in PubMed
2024-12-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ramcharan SS
2Pellegrin FAF A
3Ray RMR M
4Hsu JPJ P

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Contraceptives, OralMajor topic
Adolescent
Adult
California
Female
Humans
Middle Aged
Prospective Studies

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
41020076Recent investigations on the impact of levonorgestrel and 17β-ethinylestradiol on melanoma.J Med Life2025https://conductscience.org/library/papers/41020076PubMed
34356998Impact of Contraception on Uterine Fibroids.Medicina (Kaunas)2021https://conductscience.org/library/papers/34356998PubMed
26744813Epidemiology of Uterine Fibroids: From Menarche to Menopause.Clin Obstet Gynecol2016https://conductscience.org/library/papers/26744813PubMed
26528056Management of endometrial modifications in perimenopausal women.Clujul Med2015https://conductscience.org/library/papers/26528056PubMed
24782304Oral contraceptives for functional ovarian cysts.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24782304PubMed
24772046Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.Gastroenterol Hepatol (N Y)2013https://conductscience.org/library/papers/24772046PubMed
22935969Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women.J Headache Pain2012https://conductscience.org/library/papers/22935969PubMed
22619368Oral contraceptives, reproductive factors and risk of inflammatory bowel disease.Gut2013https://conductscience.org/library/papers/22619368PubMed
22305976Menorrhagia.BMJ Clin Evid2012https://conductscience.org/library/papers/22305976PubMed
21687478Four decades of research on hormonal contraception.Perm J2005https://conductscience.org/library/papers/21687478PubMed
19445802Menorrhagia.BMJ Clin Evid2008https://conductscience.org/library/papers/19445802PubMed
15054460Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study.Br J Cancer2004https://conductscience.org/library/papers/15054460PubMed
14718211Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.Am J Epidemiol2004https://conductscience.org/library/papers/14718211PubMed
14717620Benefits and risks of pharmacological agents used for the treatment of menorrhagia.Drug Saf2004https://conductscience.org/library/papers/14717620PubMed
12650633Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf2003https://conductscience.org/library/papers/12650633PubMed
12381211Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?Drug Saf2002https://conductscience.org/library/papers/12381211PubMed
11676302Oral contraceptives and cancer: an update.Drug Saf2001https://conductscience.org/library/papers/11676302PubMed
11085198Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Drugs2000https://conductscience.org/library/papers/11085198PubMed
6516346Oral contraceptives and venous thrombosis.West J Med1984https://conductscience.org/library/papers/6516346PubMed
6089441Systemic effects of oral contraceptives.West J Med1984https://conductscience.org/library/papers/6089441PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7205804

GET https://conductscience.org/api/papers/v1/7205804/cited_by?page=2